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Helicobacter pylori infection occurs all over the world, and more than half of the world 
population is infected by this microorganism. Research on the variety of H. pylori genes 
is valuable from two perspectives; first, for predicting the outcome of the infection and 
second, for better understanding of its distribution in the world and the evolutionary 
origins of this organism.    
 
It has been suggested that Helicobacter pylori strains containing cagA gene and the 
s1/m1 genotype of vacuolating cytotoxin gene A (vacA) may be associated with peptic 
ulcer diseases. Some studies have also shown that allele s1 of the vacA gene is 
associated with gastroduodenal diseases.  
 
 iii
In order to investigate the cagA and vacA genes, biopsies of the antrum and corpus of the 
stomachs of patients were obtained. To detect H. pylori infection, the 
phosphoglucosamine mutase gene (glmM) was amplified through the PCR method and 
observed on 2% (w/v) agarose gel electrophoresis. All the H. pylori-positive samples 
were subjected to further PCR amplification to determine different alleles of the vacA 
gene. The PCR products were separated on 2% (w/v) agarose gels electrophoresis. 37, 
15 and 32 out of 84 specimens were duodenal ulcer (DU), gastric ulcer (GU) and 
gastritis (GT), respectively. Seventy-seven (91.7%, χ2= 58.333, p < 0.05) out of 84 
samples were H. pylori-positive. cagA gene was detected in 80% (χ2= 12.6, p < 0.001), 
76.9% (χ2= 3.769, p > 0.05), and 48.3% (χ2= 0.034 p > 0.05) from DU, GU and GT 
samples, respectively. It was found that 66% (23/35) of DU samples, 62% (8/13) of GU 
samples and none of 29 GT samples were s1/m1. 17% (6/35) of DU samples, 15% 
(2/13) of GU samples and 52% (16/29) of GT samples were s1/m2. 17% (6/35) of DU 
samples, 23% (3/13) of GU samples and 48% (13/29) of GT samples were s2/m2.  
 
This study demonstrates that the presence of the m2 allele of vacA is strongly associated 
with gastritis and the presence of allele s1 is associated with peptic ulcers. Helicobacter 
pylori strains with vacA-s1/m2-cagA+ genotype are associated with peptic ulceration 
diseases.   
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Infeksi Helicobacter pylori berlaku di seluruh dunia dan lebih separuh daripada populasi 
penduduk dunia dijangkiti dengan mikroorganisma ini. Kajian terhadap berbagai-bagai 
jenis gen adalah bernilai daripada dua perspektif; pertama, untuk menjangka hasil 
daripada jangkitan. Kedua, untuk mendapat kefahaman yang lebih mendalam terhadap 
taburan kepelbagaiannya di dunia dan permulaan evolusi organisma ini. 
 
Adalah dicadangkan bahawa jenis Helicobacter pylori mengandungi gen cagA dan 
genotaip s1/m1 sitotoksin genA bervakuol (vacA) yang berkemungkinan berkaitan 
dengan penyakit radang perut. Sesetengah kajian ada menunjukkan alel s1 gen vacA 
adalah berkaitan dengan penyakit radang pangkal usus. 
 
 v
Dalam mengenalpasti gen cagA dan vacA, biopsi antrum dan korpus perut pesakit 
diperolehi. Untuk mengesan infeksi, gen phosphoglucosamine mutase (glmM) telah 
diamplikasikan menggunakan kaedah PCR dan diperhatikan pada elektroforesis 2% 
(w/v) gel agar. Semua sampel positif  H. Pylori ditentukan untuk amplifikasi PCR 
selanjutnya atau menentukan pelbagai alel gen vacA. Hasil daripada PCR telah 
diasingkan pada elektroforesis 2% (w/v) gel agar. Daripada 84 spesimen, 37 adalah 
radang duodenum (DU),15 adalah radang gastrik (GU) dan 32 ialah gastritis (GT) . 
Sebanyak tujuh puluh tujuh (91.7%, χ2= 58.333, p < 0.05) daripada 84 sampels adalah 
positif H. Pylori. Gen cagA telah dikesan dalam 80% (χ2= 12.6, p < 0.001) daripada 
sampel DU, 76.9% (χ2= 3.769, p > 0.05) daripada sampel GU dan 48.3% (χ2= 0.034 p > 
0.05) dari sampel GT. Didapati 66% (23/35) dari sampel DU, 62% (8/13) dari sampel 
GU adalah s1/m1 dan tiada pada sampel 29 GT dikesan. Sebanyak 17% (6/35) daripada 
DU sampel, 15% (2/13) adalah sampel GU dan 52% (16/29) sampel GT adalah s1/m2. 
Sebanyak 17% (6/35) dari DU sampel, 23% (3/13) adalah sampel GU dan 48% (13/29) 
sampel GT adalah s2/m2. 
 
Kajian ini menunjukkan alel m2 dari vacA adalah sangat berkait rapat dengan gastritis 
dan kehadiran alel s1 adalah berkaitan dengan radang penghadaman. Jenis Helicobacter 
pylori dengan genotaip vacA-s1/m2-cagA+ adalah berkaitan dengan penyakit radangan 
penghadaman. 
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CHAPTER 1 
INTRODUCTION 
 
Peptic ulcer is a gastrointestinal disease which is characterized by mucosal damage 
secondary to pepsin and excess gastric acid secretion. It usually occurs in the 
proximal duodenum and stomach. It can also happen in the lower esophagus, the 
jejunum, and the end of duodenum (Ramakrishnan et al., 2007). 
 
Many different factors contribute to gastrointestinal diseases, such as old age, 
tobacco smoking (Luo et al., 2002), the use of nonsteroidal anti-inflammatory drugs 
(NSAIDs) and Helicobacter pylori infection (Kurata et al., 1997). A collection of 
other infections such as tuberculosis, Crohn’s disease, myeloproliferative disorder, 
chronic renal failure, and sarcoidosis can be associated with a larger risk of peptic 
ulce. Critical illness, surgery, or hypovolemia can result in gastroduodenal corrosions 
or ulcers; these may have some complications such as bleeding or perforation and 
can be silent (Ziegler 2005). 
 
Active chronic gastritis is the most common type of chronic gastric inflammation 
that H. pylori has been detected in 70% - 80% of cases of this disease (Cover & 
Blaser 1995). The disease influences the antrum and fundus of the stomach, 
frequently showing permeation of the lymphocytes and eosinophils. The 
inflammatory process is more considerable in the antrum than other parts of the body 
(Atherton et al., 1996). 
 
H. pylori can settle in the gastric mucosa and remain there for many years with 
minimal symptoms and complications in the majority of cases (Blaser et al., 1995). It 
infected about 50% of the world’s population (Souto et al., 1998). However, it has 
been reported that some cases have shown significant morphological changes in the 
gastric mucosa-inflammation to ulceration. Others indicated the progression of 
chronic gastritis to cancer through chronic atrophic gastritis, intestinal metaplasia, 
dysplasia and carcinoma (Blaser et al., 1995). 
 
The high incidence of H. pylori infection may cause around 40 percent of all gastric 
cancer cases all over the world (Parkin et al., 2001). The International Agency for 
Research on Cancer (IARC) in 1994 reported that there is a relationship between H. 
pylori infection and gastric cancer. They found sufficient evidences that introduced 
H. pylori as a carcinogen among human populations. They classified H. pylori as 
group I definite carcinogen (Chen et al., 2007). Yamagata et al. (2000) reported a 
significant relationship between H. pylori infection and a succeeding incidence of 
gastric cancer for men in the Japanese population. 
 
Torres et al. showed that about 80% of population is infected by H. pylori at an 
average age of 10 years and 20% of one-year-old children in Mexico had antibodies 
against H. pylori (Torres et al., 1998). H. pylori Infection has significantly different 
rates between developing and developed countries. For instance, the annual 
prevalence of H. pylori infection in the United States is 0.5% to 1% in children less 
than 10 years of age and 50% in adults around 60 years old, respectively. Different 
ethnic groups, for example Hispanics, Afro-Americans, and Native Americans are 
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infected at an early period of aging (Everhart et al., 2000). Generally, low prevalence 
of H. pylori infection has been observed in the United States, Canada, northern and 
western Europe, whereas high prevalence of the infection has been reported in India, 
Africa and Latin America (Torres et al., 2000). 
 
The pathogenic effect of H. pylori in duodenal ulcer and gastric ulcer is obvious. 
Eighty percent of patients with gastric ulcer and 95% of patients with duodena ulcer 
have H. pylori infection in the United States (Breuer et al., 1998) which is the major 
cause of peptic ulcer disease in 48% of cases in the U.S. (Ramakrishnan 2007). 
However, the prevalence of H. pylori infection has been reported in about 90% of 
patients with gastroduodenal diseases in Spain (Arroyo et al., 2004). 
 
A seroepidemiological study in Iran demonstrated that 42.7% of cases between 10 to 
25 years old were seropositive for H. pylori infection. There was an age-related raise 
in H. pylori infection although there was no significant relationship between H. 
pylori infection and gender (Pirouz et al., 2000). Many studies have reported that 
85% of the Iranian adult population has H. pylori infection (Malekzadeh et al., 
2004). 
 
Helicobacter pylori is a Gram-negative, spiral, microaerophilic bacterium that 
chronically infects the gastric mucosa of more than half of the world population. 
(Parsonnet 1995.) Two putative virulence agents of H. pylori have been recognized 
in ulcerogenic strains. The first one is cytotoxin associated geneA (cagA) and the 
second is vacuolating cytotoxin geneA (vacA) (Hsu et al., 2002).  
3 
 
A 120-140 kDa protein is encoded by the cagA gene and is present in about 60-70% 
of H. pylori strains. This gene is part of the cag pathogenicity island (PAI), a 40-kbp 
fragment with a number of genes contributing to cytokine production (Hsu et al., 
2002). Strains that do not produce the CagA protein normally lack the whole cag 
PAI.  Current studies have shown that the frequency of H. pylori strains with the 
cagA gene is higher in patients with peptic ulcer disease than in patients with chronic 
gastritis (Guerrero et al., 2000).  
 
The vacuolating cytotoxin gene (vacA) is another virulence factor in that its product, 
VacA protein, can damage epithelial cells (Hsu et al., 2002). The presence of the 
vacA gene has been proven in almost all H. pylori strains and contains two variable 
parts, the s-region and m-region (Atherton et al., 1997). Each of these two regions 
has the different allelic types, s1 and s2 for the s-region and m-region containing m1 
and m2 allelic forms (Van Doorn   et al., 1998). 
 
Some reports show that type s1 is associated with peptic ulcer disease and it also has 
a significant relationship with the presence of the cagA gene (Rudi et al., 1999). m1 
allele has been observed more in severe gastric epithelial than m2 allele and it is 
associated with higher levels of toxin activity (Atherton et al.,1997). 
 
There are four combinations of vacA; therefore, the genotype s2/m1 was not 
identified in many studies (Castillo-Rojas et al., 2004). Type s1/m1 and s1/m2 strains 
produce high and moderate levels of toxin, respectively, while strains with the s2/m2 
genotype produce little or no toxin (Forsyth et al., 1998). Some studies in a number 
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of countries have demonstrated that cagA+ and vacA type s1 are associated with H. 
pylori causing peptic ulcer disease (Catalano et al., 2001). Many publications in 
Brazil have also proven this relationship (Brito et al., 2000). A recent study in Iran 
revealed that duodenal ulcer has a strong association with H. pylori infection (Rasmi 
et al., 2009), whereas another study in Tehran, capital city of Iran, showed no 
significant relationship between different genotype of H. pylori and outcomes (Jafari 
et al., 2008). 
 
Research on the variety of H. pylori genes is valuable from two perspectives; first, 
for predicting the outcome of the infection and second, for better understanding of its 
distribution in the world and the evolutionary origins of this microorganism. The 
detection of vacA and cagA, virulence markers described in several clinical 
outcomes, can be used to help the treatment and prevention of H. pylori infection in 
Iran. This study investigated different genotypes of vacA and cagA genes of 
Helicobacter pylori isolated from patients with peptic ulcers and their relationship 
with this disease.  
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The objectives of this study were to:  
 
1- Detect H. pylori infection by the PCR method in patients with peptic ulcers and 
gastritis 
2- Identify the vacA and cagA genes in patients 
3- Determine the distribution of cagA and vacA genes among patients with peptic 
ulcer and gastritis. 
4- Investigate the association between cagA gene with vacA gene and their 
relationship with gastroduodenal diseases 
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